Abstracts / Abstrakts
- 95) Belz GG, Butzer R, Kober S, Mang C, Mutschler E, Greater
extent and duration of antagonism of irbesartan on angiotensin ll
pressor response and radioligand binding in man compared to losartan
and valsartan. S Afr J Sci 1998;94:V.
- 96) Belz GG, Mang C, Butzer R, Breithaupt-Grögler
K, Fuchs W. Candesartan cilexetil has the highest
pharmacologic potency of various AT1 antagonists – assessed
by the Schild regression technique in man. J Hypertension 1999;17(Suppl.3):S66.
- 97) Belz GG, Butzer R, Kober S, Mang C, Mutschler E. Greater
extent and duration of antagonism of Irbesartan on angiotensin ll
pressor response and radioligand binding in man compared to Losartan
and Valsartan. J Am Coll Cardiol 1999;33(Suppl.A): 284A-285A.
- 98) Kober S, Butzer R, Mang C, Rönz T, Hausdorf C,
Langguth P, Belz GG. Mutschler E. Extent
and duration of angiotensin II antagonistic activity of irbesartan
and candesartan cilexetil. N S Arch Pharmacol 2000;361(Suppl.):R
130.
- 99) Kober S, Butzer R, Langguth P, Mang C, Hausdorf C,
Roenz T, Belz GG. Mutschler E. Extent
and duration of angiotensin II antagonistic activity of irbesartan
and candesartan cilexetil. Am J Hypertens 2000;13:150A.
- 100) Belz GG, Butzer R, Kober S, Langguth P, Mang C, Hausdorf
C, Roenz T, Mutschler E. Irbesartan results in more complete
blockade of human renal AT1-receptor mediated effects than does
candesartan cilexetil as evidenced by higher plasma renin levels.
Am J Hypertens 2000;13:151A.
- 101) Belz GG, Mang C, Butzer R, Breithaupt-Grögler
K. Comparative
potency of various AT1 antagonists using the Schild regression technique
in man. J Hypertens 2000;18(Suppl.2): S158.
- 102) Kober S, Butzer R, Langguth P, Mang C, Hausdorf C,
Roenz T, Belz GG, Mutschler E. Extent and duration of
angiotensin II antagonistic activity of irbesartan and candesartan
cilexetil. J Hypertens 2000;18(Suppl.2):S209.
- 103) Butzer R, Belz GG, Kober S, Langguth P, Mang C, Hausdorf
C, Roenz T, Mutschler E. Irbesartan results in more complete
blockade of human adrenal AT1-receptor mediated effects than does
candesartan cilexetil as evidenced by blunted plasma aldosterone
levels. J Hypertens 2000;18(Suppl.2):S209.
- 104) Belz GG, Butzer R, Kober S, Langguth P, Mang C, Hausdorf
C, Roenz T, Mutschler E. Irbesartan results in more complete
blockade of human renal AT1-receptor mediated effects than does
candesartan cilexetil as evidenced by higher plasma renin levels.
Eur J Clin Pharmacol 2000;56:A19.
- 105) Barry M, Belz G, Roll S, O'Grady P, Swaminathan A,
Geraldes M, Mangold B. Interaction of nelfinavir with
atorvastatin and pravastatin in normal healthy volunteers.
AIDS 2000;14(Suppl.4):S90.
- 106) Belz GG, Butzer R. A clinical pharmacological
approach for characterizing AT1 receptor antagonists. Eur J Clin
Pharmacol 2001;57:A20.
- 107) Belz GG, Breithaupt-Grögler K, Roll
S, Mangold B, Reeves RA, Strack E. Differential effects of omapatrilat
and hydrochlorothiazide on arterial function in hypertension. Eur
Heart J 2002;23(Suppl):327.
< 1 2 3 4 5 6 7 8